Chemistry: molecular biology and microbiology – Vector – per se
Reexamination Certificate
2007-03-13
2007-03-13
Priebe, Scott D. (Department: 1633)
Chemistry: molecular biology and microbiology
Vector, per se
C435S091400, C435S455000, C435S456000, C435S366000, C536S023720, C424S093200
Reexamination Certificate
active
10946484
ABSTRACT:
Methods, cells and recombinant adenoviral vectors are disclosed that permit the production of recombinant adenoviral vector stocks with reduced levels of contamination by replication competent adenoviruses (RCA). In certain embodiments are disclosed early region 1 (E1) deficient recombinant adenoviral vectors and complementing E1 positive host cells whose sequences are designed to avoid formation of RCA by homologous recombination between sequences in the vector and E1 sequences in the cells. One aspect of the invention involves the inversion of the packaging signal in a recombinant adenoviral vector relative to an adjacent or nearby inverted terminal repeat (ITR). Methods include use of site-specific intregrase family recombinases such as Cre or FLP and recombinase recognition sites such as lox sites or frt sites.
REFERENCES:
patent: 5880102 (1999-03-01), George et al.
patent: 6265212 (2001-07-01), Fallaux et al.
patent: 6692966 (2004-02-01), Fallaux et al.
Ng, P. et al. “Cre Levels Limit Packaging Signal Excision Efficiency in the Cre/loxP Helper-Dependent Adenoviral Vector System”, 2002, J. Virol., vol. 76: pp. 4181-4189.
Parks, R. et al., “A helper-dependent adenovirus vector system: Removal of helper virus by Cre-mediated excision of the viral packaging signal”, 1996, PNAS, vol. 93: pp. 13565-13570.
Palmer, Donna et al.,Improved System for Helper-Dependent Adenoviral Vector Production, Molecular Therapy, vol. 8, No. 5, Nov. 2003, pp. 846-852.
Hearing, Patrick, et al.,Identification of a Repeated Sequence Element Required for Efficient Encapsidation of the Adenovirus Type 5 Chromosome, Journal of Virology, vol. 61, No. 8, Aug. 1987, pp. 2555-2558.
Suzuki, Erika et al.,A Simple Method for the Simultaneous Detection of E1A and E1B in Adenovirus Stocks, Oncology Reports 11, 2004, pp. 173-178.
Soudais, Claire,Characterization of cis-Acting Sequences Involved in Canine Adenovirus Packaging, Molecular Therapy, vol. 3, No. 4, Apr. 2001, pp. 631-640.
Schmid, Susanne I. Et al.,Cellular Components Interact with Adenovirus Type 5 Minimal DNA Packaging Domains, Journal of Virology, vol. 72, No. 8, Aug. 1998, pp. 6339-6347.
Sandig, Volker et al.,Optimization of the Helper-Dependent Adenovirus System for Production and Potency in Vivo, PNAS, vol. 97, No. 3, Feb. 2000, pp. 1002-1007.
AdVec, Inc.
Beusse Wolter Sanks Mora & Maire, P.A.
Burkhart Michael
Fischer Joseph
Priebe Scott D.
LandOfFree
Production of adenovirus vectors with reduced levels of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Production of adenovirus vectors with reduced levels of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Production of adenovirus vectors with reduced levels of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3795679